We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Groups around the world are working hard to develop HIV vaccines, but in the meantime, Gilead Sciences reports that Truvada can significantly reduce the rate of new infections when used as a pre-exposure prophylaxis.